Organization
Children's Hospital Colorado, Aurora, CO
7 abstracts
Abstract
Genomic determinants of outcome in acute lymphoblastic leukemia: A Children’s Oncology Group study.Org: St. Jude Children’s Research Hospital, Memphis, TN, The Hospital for Sick Children, Toronto, ON, Canada, Perlmutter Cancer Center and NYU Langone, New York, NY, Children's Hospital of Alabama, Birmingham, AL, Children's Hospital Colorado, Aurora, CO,
Abstract
Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.Org: Children's Hospital Colorado, Aurora, CO, Children's Oncology Group Statistics and Data Center, University of Florida, Baylor College of Medicine, Children's Hospital of Philadelphia, Roswell Park Cancer Institute Department of Cancer Prevention and Population Sciences,
Abstract
Vincristine (VCR) pharmacokinetics (PK) in infants dosed using a body surface area (BSA) banded dosing table and in older children dosed based on BSA: A pediatric early phase clinical trial network study (PEPN22P1).Org: Children's Hospital Colorado, Aurora, CO, Children's Hospital of Philadelphia, Children's Oncology Group Statistics and Data Center, University of Florida, Texas Children's Cancer and Hematology Center, Institute for Clinical and Translational Research, Baylor College of Medicine,
Abstract
Site research infrastructure and institutional performance: A report from the Voting Body of the Children’s Oncology Group (COG).Org: University of Oklahoma Health Sciences Center, Georgetown University Lombardi Comprehensive Cancer Center, St. Luke's Cancer Institute, Children's Hospital Colorado, Aurora, CO, University of California Davis, Sacramento, CA,
Abstract
Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma.Org: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College University, Massachusetts General Hospital, Sarah Cannon Research Institute/Tennessee Oncology, Children's Hospital Colorado, Aurora, CO,
Abstract
Evaluation of palbociclib in combination with topotecan and cyclophosphamide in pediatric patients with recurrent or refractory neuroblastoma.Org: Children’s Hospital of Philadelphia, Abramson Cancer Center, University of Pennsylvania, Children's Hospital Los Angeles Department of Pediatrics, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital,
Abstract
Subsequent meningiomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of Alberta, University of Minnesota Masonic Cancer Center, Minneapolis, MN, Fred Hutchinson Cancer Research Center, MD Anderson Cancer Center,